Al-Razi Medical Company (TADAWUL:9572)

Market Cap	38.61M -29.4%
Revenue (ttm)	76.40M +19.1%
Net Income	1.12M +298.4%
EPS	0.74 +298.4%
Shares Out	1.52M
PE Ratio	34.40
Forward PE	n/a
Dividend	1.59 (6.10%)
Ex-Dividend Date	n/a

Volume	18,714
Open	26.98
Previous Close	26.70
Day's Range	25.00 - 26.98
52-Week Range	25.00 - 40.10
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 2, 2026

About Al-Razi Medical Company

Al-Razi Medical Company engages in the retail sale of medical devices, equipment, and supplies in the Kingdom of Saudi Arabia. The company is involved in the operation of medical device, cosmetic, and pharmaceutical warehouses; specialized and general medical complexes; and one-day surgery centers. It also engages in the land transport of goods; operation of storage facilities; and provision of shipping and distribution services. The company was founded in 1986 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1986
• Employees: 123
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 9572

Financial Performance

In 2025, Al-Razi Medical Company's revenue was 74.38 million, an increase of 21.24% compared to the previous year's 61.35 million. Earnings were 819,462, an increase of 365.96%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error